Insider Transactions Screener
Search for and identify insider purchases or sales of company shares. The screener offers additional information and analysis on the transactions and allows users to set up alerts and receive notifications when new transactions occur.
Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
---|---|---|---|---|---|---|
AAOI
|
Chih Hsiang (Thompson) Lin
President and CEO |
SELL
Open market or private sale
|
Direct | 7,788 Reduced 0.97% |
$87,381
$11.22 p/Share
|
Oct 01
2020 |
BTN
|
Fundamental Global Investors, LLC
Director |
BUY
Open market or private purchase
|
Indirect | 700 Added 0.07% |
$1,120
$1.6 p/Share
|
Oct 01
2020 |
PCSA
|
Patrick Lin
Chief Business - Strategy Off |
BUY
Open market or private purchase
|
Direct | 31,250 Added 7.25% |
$65,625
$2.1 p/Share
|
Oct 01
2020 |
PCSA
|
James H Stanker
Chief Financial Officer |
BUY
Open market or private purchase
|
Direct | 6,000 Added 11.27% |
$12,600
$2.1 p/Share
|
Oct 01
2020 |
FREQ
|
David L. Lucchino |
SELL
Open market or private sale
|
Direct | 15,716 Reduced 4.24% |
$303,162
$19.29 p/Share
|
Oct 01
2020 |
FREQ
|
Christopher R. Loose
Chief Scientific Officer |
SELL
Open market or private sale
|
Direct | 8,000 Reduced 5.56% |
$150,720
$18.84 p/Share
|
Oct 01
2020 |
CULP
|
Fred A Jackson
Director |
BUY
Grant, award, or other acquisition
|
Direct | 1,020 Added 3.06% |
-
|
Oct 01
2020 |
CULP
|
Kenneth R Larson
Director |
BUY
Grant, award, or other acquisition
|
Direct | 1,020 Added 4.83% |
-
|
Oct 01
2020 |
CULP
|
Kenneth W Mcallister
Director |
BUY
Grant, award, or other acquisition
|
Direct | 1,113 Added 2.77% |
-
|
Oct 01
2020 |
CULP
|
Perry E Davis
Director |
BUY
Grant, award, or other acquisition
|
Direct | 1,020 Added 12.65% |
-
|
Oct 01
2020 |
CULP
|
Sharon A Decker
Director |
BUY
Grant, award, or other acquisition
|
Direct | 1,020 Added 11.62% |
-
|
Oct 01
2020 |
NTIP
|
Steven D. Heinemann
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 200 Reduced 0.01% |
$570
$2.85 p/Share
|
Oct 01
2020 |
LFVN
|
Steven R Fife
President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct | 1,674 Reduced 1.08% |
$19,837
$11.85 p/Share
|
Oct 01
2020 |
LFVN
|
Steven R Fife
President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct | 2,770 Added 1.76% |
-
|
Oct 01
2020 |
LFVN
|
Kevin Mc Murray
General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct | 672 Reduced 1.33% |
$7,963
$11.85 p/Share
|
Oct 01
2020 |
LFVN
|
Kevin Mc Murray
General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct | 981 Added 1.91% |
-
|
Oct 01
2020 |
LFVN
|
Justin Rose
Chief Sales Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 864 Reduced 0.56% |
$10,238
$11.85 p/Share
|
Oct 01
2020 |
LFVN
|
Justin Rose
Chief Sales Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 1,178 Added 0.76% |
-
|
Oct 01
2020 |
LFVN
|
Charles J. Wach
Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 752 Reduced 2.05% |
$8,911
$11.85 p/Share
|
Oct 01
2020 |
LFVN
|
Charles J. Wach
Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 981 Added 2.6% |
-
|
Oct 01
2020 |
HARP
|
Holger Wesche
Chief Scientific Officer |
SELL
Open market or private sale
|
Direct | 10,000 Reduced 15.96% |
$166,100
$16.61 p/Share
|
Oct 01
2020 |
HARP
|
Holger Wesche
Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 10,000 Added 13.76% |
$6,000
$0.6 p/Share
|
Oct 01
2020 |
LKCRU
|
Alan Mundt Scott
Chief Executive Officer |
BUY
Open market or private purchase
|
Direct | 20,000 Added 25.0% |
$30,200
$1.51 p/Share
|
Oct 01
2020 |
LKCRU
|
Rick Alan Kasperson
Director |
BUY
Open market or private purchase
|
Indirect | 15,000 Added 11.54% |
$22,500
$1.5 p/Share
|
Oct 01
2020 |
NAII
|
Michael E Fortin
Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 2,479 Reduced 4.34% |
$18,345
$7.4 p/Share
|
Oct 01
2020 |
NAII
|
Kenneth Wolf
President, COO, & Sec. |
SELL
Payment of exercise price or tax liability
|
Direct | 5,265 Reduced 3.77% |
$38,961
$7.4 p/Share
|
Oct 01
2020 |
PCF
|
Phillip Goldstein
Director |
SELL
Open market or private sale
|
Direct | 8,301 Reduced 8.01% |
$69,147
$8.33 p/Share
|
Oct 01
2020 |
SRT
|
Julie Schoenfeld
Director |
BUY
Grant, award, or other acquisition
|
Direct | 4,302 Added 12.35% |
-
|
Oct 01
2020 |
MLVF
|
James W Barrett
Director |
BUY
Open market or private purchase
|
Direct | 221 Added 1.76% |
$2,648
$11.98 p/Share
|
Oct 01
2020 |
MLVF
|
Julia D Corelli
Director |
BUY
Open market or private purchase
|
Direct | 201 Added 2.95% |
$2,408
$11.98 p/Share
|
Oct 01
2020 |
MLVF
|
Norman Feinstein
Director |
BUY
Open market or private purchase
|
Indirect | 241 Added 1.86% |
$2,887
$11.98 p/Share
|
Oct 01
2020 |
MLVF
|
Andrew D. Fish
Director |
BUY
Open market or private purchase
|
Direct | 241 Added 6.01% |
$2,887
$11.98 p/Share
|
Oct 01
2020 |
MLVF
|
Howard Kent
Director |
BUY
Open market or private purchase
|
Direct | 318 Added 0.2% |
$3,810
$11.98 p/Share
|
Oct 01
2020 |
MLVF
|
Cynthia F Leitzell
Director |
BUY
Open market or private purchase
|
Direct | 243 Added 1.45% |
$2,911
$11.98 p/Share
|
Oct 01
2020 |
MLVF
|
Stephen P Scartozzi
Director |
BUY
Open market or private purchase
|
Direct | 221 Added 3.23% |
$2,648
$11.98 p/Share
|
Oct 01
2020 |
CTO
|
Matthew Morris Partridge
SR. VP, CFO & TREASURER |
BUY
Grant, award, or other acquisition
|
Direct | 4,000 Added 50.0% |
-
|
Oct 01
2020 |
PTE
|
Denver Lough |
BUY
Exercise of conversion of derivative security
|
Direct | 11,111 Added 0.15% |
-
|
Oct 01
2020 |
PTE
|
Minnie Baylor Henry
Director |
BUY
Grant, award, or other acquisition
|
Direct | 12,135 Added 14.99% |
$12,499
$1.03 p/Share
|
Oct 01
2020 |
PTE
|
Peter A Cohen
Director |
BUY
Grant, award, or other acquisition
|
Direct | 36,165 Added 13.41% |
$37,250
$1.03 p/Share
|
Oct 01
2020 |
CPHC
|
Mark Chronister
Director |
BUY
Grant, award, or other acquisition
|
Direct | 2,098 Added 50.0% |
-
|
Oct 01
2020 |
PSNL
|
Richard Chen
CHIEF MEDICAL OFFICER AND EVP |
SELL
Open market or private sale
|
Direct | 40,000 Reduced 26.19% |
$878,800
$21.97 p/Share
|
Oct 01
2020 |
PSNL
|
Richard Chen
CHIEF MEDICAL OFFICER AND EVP |
BUY
Exercise of conversion of derivative security
|
Direct | 37,452 Added 19.69% |
$16,479
$0.44 p/Share
|
Oct 01
2020 |
COFS
|
James A Bosserd
Director |
BUY
Grant, award, or other acquisition
|
Direct | 96 Added 0.68% |
$2,498
$26.02 p/Share
|
Oct 01
2020 |
COFS
|
Keith D. Brophy
Director |
BUY
Grant, award, or other acquisition
|
Indirect | 260 Added 5.9% |
$6,765
$26.02 p/Share
|
Oct 01
2020 |
COFS
|
Harold J Burns
Director |
BUY
Grant, award, or other acquisition
|
Direct | 423 Added 4.06% |
$11,006
$26.02 p/Share
|
Oct 01
2020 |
COFS
|
Eric E Burrough
Director |
BUY
Grant, award, or other acquisition
|
Direct | 423 Added 0.33% |
$11,006
$26.02 p/Share
|
Oct 01
2020 |
COFS
|
David Bush
Director |
BUY
Grant, award, or other acquisition
|
Direct | 177 Added 0.14% |
$4,606
$26.02 p/Share
|
Oct 01
2020 |
COFS
|
Bruce Cady
Director |
BUY
Grant, award, or other acquisition
|
Direct | 96 Added 25.6% |
$2,498
$26.02 p/Share
|
Oct 01
2020 |
COFS
|
Patrick Cronin
Director |
BUY
Grant, award, or other acquisition
|
Indirect | 96 Added 25.6% |
$2,498
$26.02 p/Share
|
Oct 01
2020 |
COFS
|
Jack Hendon
Director |
BUY
Grant, award, or other acquisition
|
Indirect | 259 Added 4.73% |
$6,739
$26.02 p/Share
|
Oct 01
2020 |